Skip to main content

Advertisement

Log in

ASO Author Reflection: Fertility-Sparing Surgery for Early-Stage Cervical Cancer—What Perspectives Between Oncological Prognosis and Obstetrical Future?

  • ASO Author Reflections
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Dargent D, Brun JL, Roy M, Mathevet P, Rémy I. La trachélectomie élargie : une alternative à l’hystérectomie radicale dans le traitement des cancers infiltrants développés sur la face externe du col utérin. Jobgyn 1994;2:285-92.

    Google Scholar 

  2. Ramirez PT, Frumovitz M, Pareja R, Lopez A, Vieira M, Ribeiro R, et al. Minimally invasive versus abdominal radical hysterectomy for cervical cancer. N Engl J Med. 2018;379(20):1895–904.

    Article  Google Scholar 

  3. Belghiti J, Favier A, Uzan C, Motton C, Canlorbe G, Azaïs H. Robotic radical trachelectomy with primary vaginal closure to spare fertility in young patient with early-stage cervical cancer. Ann Surg Oncol. 2021. https://doi.org/10.1245/s10434-021-10550-9.

    Article  PubMed  Google Scholar 

  4. Chiva L, Zanagnolo V, Querleu D, Martin-Calvo N, Arévalo-Serrano J, Căpîlna ME, et al. SUCCOR study: an international European cohort observational study comparing minimally invasive surgery versus open abdominal radical hysterectomy in patients with stage IB1 cervical cancer. Int J Gynecol Cancer. 2020;30(9):1269–77.

    Article  Google Scholar 

  5. de Vincenzo R, Ricci C, Fanfani F, Gui B, Gallotta V, Fagotti A, et al. Neoadjuvant chemotherapy followed by conization in stage IB2-IIA1 cervical cancer larger than 2 cm: a pilot study. Fertil Steril. 2021;115(1):148–56.

    Article  Google Scholar 

  6. Plante M, van Trommel N, Lheureux S, Oza AM, Wang L, Sikorska K, et al. FIGO 2018 stage IB2 (2–4 cm) Cervical cancer treated with Neo-adjuvant chemotherapy followed by fertility Sparing Surgery (CONTESSA); Neo-Adjuvant Chemotherapy and Conservative Surgery in Cervical Cancer to Preserve Fertility (NEOCON-F). A PMHC, DGOG, GCIG/CCRN and multicenter study. Int J Gynecol Cancer. 2019;29(5):969–75.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Henri Azaïs MD, PhD.

Ethics declarations

Disclosures

Jérémie Belghiti reports personal fees and non-financial support from Intuitive Surgical for educational services, speaking engagements and proctoring, outside the submitted work. Geoffroy Canlorbe reports personal fees and non-financial support from Intuitive Surgical for educational services, speaking engagements and proctoring. He also reports personal fees and non-financial support from Gedeon Richter for speaking engagements, outside the submitted work. Henri Azaïs and Catherine Uzan have no conflicts of interest to disclose.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Azaïs, H., Canlorbe, G., Uzan, C. et al. ASO Author Reflection: Fertility-Sparing Surgery for Early-Stage Cervical Cancer—What Perspectives Between Oncological Prognosis and Obstetrical Future?. Ann Surg Oncol 29, 681–682 (2022). https://doi.org/10.1245/s10434-021-10780-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-021-10780-x

Navigation